,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-05-21 06:53:00,The Zacks Research Daily presents the best research output of our analyst team.,0.6325156092643738,0.012341027148067951,0.35514333844184875,positive,0.6201745867729187
1,2018-05-21 06:53:00,"Today's Research Daily features new research reports on 17 major stocks, including Procter & Gamble (PG), AbbVie (ABBV), McDonald's (MCD) and PepsiCo (PEP).",0.042839713394641876,0.007834222167730331,0.9493260979652405,neutral,0.035005491226911545
2,2018-05-21 06:53:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
3,2018-05-21 06:53:00,"You can see all of today's research reports here >>>

Procter & Gamble 's shares have underperformed the Zacks Soap and Cleaning Materials industry over the last six months (-16.9% vs. -10.2%).",0.20450863242149353,0.7696931958198547,0.025798214599490166,negative,-0.5651845932006836
4,2018-05-21 06:53:00,"P&G reported third-quarter fiscal 2018 results, wherein earnings and revenues surpassed expectations, benefiting from higher demand for skincare products, along with fabric and home care products.",0.9514551162719727,0.019007151946425438,0.029537636786699295,positive,0.9324479699134827
5,2018-05-21 06:53:00,"Adjusted earnings grew 4% from the year-ago level, aided by productivity cost savings.",0.9594029784202576,0.02114647440612316,0.019450554624199867,positive,0.9382565021514893
6,2018-05-21 06:53:00,"Top line grew 4% on organic sales growth of 1%, comprising 2% volume growth.",0.9267733097076416,0.015397715382277966,0.05782897397875786,positive,0.9113755822181702
7,2018-05-21 06:53:00,"The Zacks analyst emphasizes that Procter & Gamble remains focused on improved product, packaging and marketing initiatives, and productivity cost-savings plan.",0.9255908727645874,0.014272629283368587,0.06013648211956024,positive,0.9113182425498962
8,2018-05-21 06:53:00,"Meanwhile, it intends to acquire the consumer-health unit of Merck KGaA, which will enhance P&G's existing consumer healthcare capabilities.",0.9276061654090881,0.01264186017215252,0.05975199490785599,positive,0.9149643182754517
9,2018-05-21 06:53:00,"However, core gross and operating margin declined 110 bps and 100 bps, respectively, in the quarter.",0.016953766345977783,0.9722655415534973,0.010780775919556618,negative,-0.9553117752075195
10,2018-05-21 06:53:00,"Lower pricing, higher commodity costs and increased competition continued to hurt results.",0.017327021807432175,0.9681260585784912,0.014546944759786129,negative,-0.9507990479469299
11,2018-05-21 06:53:00,P&G's shares have lost around 20.1% year to date.,0.017447376623749733,0.9721338152885437,0.010418795980513096,negative,-0.9546864628791809
12,2018-05-21 06:53:00,"Estimates for fiscal 2018 and 2019 have moved down 0.2% and 1.3%, over the past 60 days.",0.017308732494711876,0.9634294509887695,0.01926175318658352,negative,-0.9461207389831543
13,2018-05-21 06:53:00,(You can read the full research report on Procter & Gamble here >>> ).,0.013788774609565735,0.010992237366735935,0.9752189517021179,neutral,0.0027965372428297997
14,2018-05-21 06:53:00,"Shares of AbbVie have gained +9.6% year to date, outperforming the Zacks Large Cap Pharmaceuticals industry, which has declined -3.8% over the same period.",0.9164493083953857,0.06528012454509735,0.018270552158355713,positive,0.8511691689491272
15,2018-05-21 06:53:00,AbbVie beat estimates for both earnings and sales in the first quarter.,0.9299854040145874,0.0444299578666687,0.02558463253080845,positive,0.8855554461479187
16,2018-05-21 06:53:00,It also raised its earnings expectations for 2018 based on strong Q1 performance and an optimistic outlook for future quarters.,0.926563560962677,0.01623469404876232,0.05720178410410881,positive,0.9103288650512695
17,2018-05-21 06:53:00,"AbbVie's key drug, Humira, has been performing well based on strong demand trends, despite new competition.",0.9525672197341919,0.01993987150490284,0.027492882683873177,positive,0.9326273202896118
18,2018-05-21 06:53:00,"Moreover, Imbruvica has multibillion dollar potential and AbbVie is exploring the possibility of label expansion into solid tumors and autoimmune diseases.",0.711133599281311,0.009994653053581715,0.2788717746734619,positive,0.701138973236084
19,2018-05-21 06:53:00,Mavyret's launch has also been stronger than expected.,0.9519012570381165,0.020478853955864906,0.027619916945695877,positive,0.9314224123954773
20,2018-05-21 06:53:00,AbbVie has an impressive late-stage pipeline with label expansions for both new and existing products expected over the next few years.,0.8751019835472107,0.010924117639660835,0.11397386342287064,positive,0.8641778826713562
21,2018-05-21 06:53:00,The Zacks analyst thinks promising data from several pivotal studies and settlement of its second Humira patent dispute with Biogen are key positives.,0.8871339559555054,0.016172025352716446,0.09669408202171326,positive,0.8709619045257568
22,2018-05-21 06:53:00,"However, Viekira's sales continue to be hurt by intensifying competition.",0.020402133464813232,0.9611741304397583,0.018423741683363914,negative,-0.9407719969749451
23,2018-05-21 06:53:00,(You can read the full research report on AbbVie here >>> ).,0.013080944307148457,0.013050665147602558,0.9738683700561523,neutral,3.0279159545898438e-05
24,2018-05-21 06:53:00,"McDonald 's shares have gained +8.6% over the past one year, outperforming the Zacks Restaurants industry which has gained +1.7% over the same period.",0.954350471496582,0.02583380974829197,0.019815707579255104,positive,0.928516685962677
25,2018-05-21 06:53:00,"The Zacks analyst thinks McDonald's impressive earnings surprise history, various sales and digital initiatives as well as positive comparable sales are major positives.",0.9099383354187012,0.01743607223033905,0.0726255476474762,positive,0.8925022482872009
26,2018-05-21 06:53:00,"Earnings surpassed the estimate for 15th straight quarter, as it reported first-quarter 2018 results.",0.9493451118469238,0.024562504142522812,0.026092447340488434,positive,0.9247826337814331
27,2018-05-21 06:53:00,"Furthermore, increased focus on delivery and accelerated deployment of Experience of the Future restaurants in the United States should boost its performance.",0.955446720123291,0.017465371638536453,0.027087954804301262,positive,0.937981367111206
28,2018-05-21 06:53:00,Efforts to attract customers in International Lead & High Growth Markets also bode well.,0.9319196939468384,0.013546347618103027,0.054534051567316055,positive,0.9183733463287354
29,2018-05-21 06:53:00,"In fact, global comps at McDonald's have been positive over the trailing eleven quarters.",0.9402585625648499,0.019702425226569176,0.04003896564245224,positive,0.9205561280250549
30,2018-05-21 06:53:00,"Yet, high labor costs and currency headwinds are major concerns.",0.02880323864519596,0.8128318190574646,0.158364936709404,negative,-0.7840285897254944
31,2018-05-21 06:53:00,"Moreover, revenues have been under pressure for quite some time due to strategic refranchising initiative.",0.04195807874202728,0.8760879039764404,0.08195402473211288,negative,-0.834129810333252
32,2018-05-21 06:53:00,"Even so, its augmented focus on refranchising should cut the capital requirements and facilitate EPS growth in the long run.",0.9347371459007263,0.031617797911167145,0.03364509716629982,positive,0.9031193256378174
33,2018-05-21 06:53:00,(You can read the full research report on McDonald here >>> ).,0.015941686928272247,0.014934190548956394,0.9691241979598999,neutral,0.0010074963793158531
34,2018-05-21 06:53:00,"Shares of PepsiCo have decreased -18.7% year to date, underperforming the Zacks Soft Beverages industry, which has declined -12.3% over the same period.",0.018416162580251694,0.9717870950698853,0.009796787984669209,negative,-0.9533709287643433
35,2018-05-21 06:53:00,PepsiCo's first-quarter 2018 earnings and revenues both beat expectations.,0.9471576809883118,0.027166452258825302,0.0256758201867342,positive,0.9199912548065186
36,2018-05-21 06:53:00,"Notably, this is the eighth consecutive quarter of positive earnings surprise.",0.8907742500305176,0.06601406633853912,0.043211791664361954,positive,0.8247601985931396
37,2018-05-21 06:53:00,"The improvement was mainly due to strong performances in its international divisions, propelled by higher revenue growth in the developing and emerging markets.",0.9591833353042603,0.017967145889997482,0.022849449887871742,positive,0.9412161707878113
38,2018-05-21 06:53:00,"Core earnings and revenues grew 3% and 4.3% year over year, respectively.",0.9570862054824829,0.021370574831962585,0.021543210372328758,positive,0.9357156157493591
39,2018-05-21 06:53:00,"Organic revenues were 2.3% in the quarter, same as the prior quarter.",0.24746073782444,0.31251221895217896,0.44002699851989746,neutral,-0.06505148112773895
40,2018-05-21 06:53:00,"However, NAB division reported dismal results with revenues and operating profit decreasing 1% and 22%, respectively.",0.02102813310921192,0.9692092537879944,0.009762585163116455,negative,-0.9481810927391052
41,2018-05-21 06:53:00,"Volumes declined 2.5%, led by 4% decline in CSDs and 1% decrease in Non CSDs.",0.02265704981982708,0.9689568281173706,0.008386165834963322,negative,-0.9462997913360596
42,2018-05-21 06:53:00,Shift in consumer preferences toward healthier options is a potent headwind.,0.053230077028274536,0.8930668234825134,0.05370311439037323,negative,-0.8398367166519165
43,2018-05-21 06:53:00,"Earnings estimates have moved 0.2% and 0.5% south for 2018 and 2019, respectively, over the past 30 days.",0.6503737568855286,0.1978675127029419,0.15175870060920715,positive,0.45250624418258667
44,2018-05-21 06:53:00,(You can read the full research report on PepsiCo here >>> ).,0.011887730099260807,0.012104537338018417,0.9760077595710754,neutral,-0.00021680723875761032
45,2018-05-21 06:53:00,"Other noteworthy reports we are featuring today include Applied Materials (AMAT), ABB Ltd. (ABB) and Itau Unibanco (ITUB).",0.03167853504419327,0.005387764889746904,0.9629337787628174,neutral,0.02629077062010765
46,2018-05-21 06:53:00,Looking for Stocks with Skyrocketing Upside?,0.09469357132911682,0.09826507419347763,0.807041347026825,neutral,-0.0035715028643608093
47,2018-05-21 06:53:00,Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.,0.41462862491607666,0.01087752915918827,0.5744938254356384,neutral,0.40375110507011414
48,2018-05-21 06:53:00,"Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021.",0.8838319182395935,0.03136736899614334,0.08480073511600494,positive,0.8524645566940308
49,2018-05-21 06:53:00,"Early investors stand to make a killing, but you have to be ready to act and know just where to look.",0.19955629110336304,0.018484661355614662,0.781959056854248,neutral,0.18107162415981293
50,2018-05-21 06:53:00,"See the pot trades we're targeting>>

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings.",0.08856207132339478,0.007175061851739883,0.904262900352478,neutral,0.08138701319694519
51,2018-05-21 06:53:00,He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trendsand Earnings Previewreports.,0.026142945513129234,0.011532393284142017,0.9623246192932129,neutral,0.014610552228987217
52,2018-05-21 06:53:00,"If you want an email notification each time Sheraz publishes a new article, please click here>>>

While Williams' buyout of its midstream unit will ease organizational structure and improve credit profile, the Zacks Analyst is concerned about the regulatory roadblocks to Constitution Pipeline.",0.6515130996704102,0.253997266292572,0.09448961168527603,positive,0.39751583337783813
53,2018-05-21 06:53:00,"Per the Zacks analyst, sales force integration efforts with profitable revenue growth will continue to benefit CenturyLink to generate incremental cash flow.",0.9503023624420166,0.016206054016947746,0.03349154815077782,positive,0.9340963363647461
54,2018-05-21 06:53:00,"Per the Zacks analyst, Applied Materials continues to benefit from technological advancement in semiconductor segment along with robust 3D NAND and patterning equipment.",0.9389833807945251,0.013746778480708599,0.04726986959576607,positive,0.9252365827560425
55,2018-05-21 06:53:00,"Per the Zacks analyst, strategy to internationalize the bank, diversification and focus on less risky products remained key strengths at Itau Unibanco.",0.902273952960968,0.012419430539011955,0.0853065550327301,positive,0.8898545503616333
56,2018-05-21 06:53:00,"Per the Zacks analyst, Kellogg's cost savings from its Project K and zero-based budgeting (ZBB) plans have been supporting renovation, innovation and margins.",0.948648989200592,0.01747768558561802,0.033873300999403,positive,0.9311712980270386
57,2018-05-21 06:53:00,"Per the Zacks analyst, Oncor acquisition will expand Sempra Energy's footprint in Texas and U.S. gulf areas.",0.945087194442749,0.01517174206674099,0.039740998297929764,positive,0.9299154281616211
58,2018-05-21 06:53:00,"Per the Zacks analyst, strong order growth in Robotics & Motion and Industrial Automation segments bode well for ABB's growth momentum.",0.9533291459083557,0.014524295926094055,0.03214665874838829,positive,0.9388048648834229
59,2018-05-21 06:53:00,"Per the Zacks analyst, continued demand for the Mako Total Knee Platform and a diversified product portfolio have consistently driven Stryker's growth.",0.9375462532043457,0.01332425232976675,0.049129389226436615,positive,0.9242219924926758
60,2018-05-21 06:53:00,"Per the Zacks analyst, strong growth in Medicare business has led to increase in membership and revenue over past several quarters.",0.9517109990119934,0.015746096149086952,0.032542940229177475,positive,0.9359648823738098
61,2018-05-21 06:53:00,The company's strong balance sheet enables strategic investments.,0.853594958782196,0.011923989281058311,0.13448098301887512,positive,0.8416709899902344
62,2018-05-21 06:53:00,The Zacks analyst believes that ADP's buyout strategy and initiatives to streamline and expand its business are key growth catalysts.,0.9187049865722656,0.0129951611161232,0.0682997852563858,positive,0.9057098031044006
63,2018-05-21 06:53:00,A strong cash position is also a positive.,0.8897324800491333,0.019239570945501328,0.09102797508239746,positive,0.8704929351806641
64,2018-05-21 06:53:00,"Per the Zacks analyst, stiff competition in the glatiramer acetate market is impacting Momenta's performance.",0.022774700075387955,0.9503621459007263,0.02686316706240177,negative,-0.9275874495506287
65,2018-05-21 06:53:00,"In addition, pipeline setbacks further cloud the growth trajectory for the company.",0.029045790433883667,0.9289748072624207,0.041979458183050156,negative,-0.8999290466308594
66,2018-05-21 06:53:00,"Per the Zacks analyst, frequent recalls are lowering vehicle resale value and raising costs for Toyota.",0.028016220778226852,0.9531167149543762,0.018867148086428642,negative,-0.9251005053520203
67,2018-05-21 06:53:00,"Further, a stronger yen may negatively impact its profitability in fiscal 2019.",0.023122092708945274,0.9415608048439026,0.035317063331604004,negative,-0.918438732624054
68,2018-05-21 06:53:00,"Per the Zacks analyst, waning gross margin and higher SG&A expenses may hurt Lowe's bottom line.",0.021962685510516167,0.966742992401123,0.011294321157038212,negative,-0.9447802901268005
69,2018-05-21 06:53:00,"Further, unfavorable weather might result in lower spring seasonal spending that can hurt sales.",0.021770576015114784,0.9605047106742859,0.01772479899227619,negative,-0.9387341141700745
70,2018-05-21 06:53:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
71,2018-05-21 06:53:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
72,2018-05-21 06:53:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
73,2018-05-21 06:53:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
